The stock's fall snapped a three-day winning streak.
Medical device specialist DexCom(NASDAQ: DXCM) is going through a rough patch. The company's shares are down sharply year to ...
器械之家医疗器械媒体报道先锋分享专业医疗器械知识关注 来源:器械之家,未经授权不得转载,且24小时后方可转载近日,全球领先的连续血糖监测仪(CGM)龙头Dexcom宣布,已向智能戒指制造商Ōura投资7500万美元(约折合5.4亿人民币),并达成战略 ...
Shares of DexCom Inc. DXCM inched 0.12% higher to $81.01 Wednesday, on what proved to be an all-around positive trading ...
DexCom的地位尤为引人注目,因为它在大盘股中脱颖而出,目前交易价格比52周高点低49%,而大多数大盘成长股仅比52周高点低1-3%。美银证券指出,如果公司的执行符合2025年的预期,DexCom提供了更大的估值倍数扩张潜力。
高估值背后,是Oura出色的商业化表现。根据前段时间公布的数据,Oura的智能戒指已经销售了250多万枚,今年的销量额将翻一番,达到5亿美金。而且,根据CEO Tom Hale的说法,Oura的利润率远高于传统硬件制造商,甚至接近软件公司。
“行业观察者”是我们针对人工智能、XR、元宇宙和Web3等前沿科技而设立的专栏,主要分享这些领域中的新兴企业或者创业者们的故事。智能戒指制造商Oura获得了美国连续血糖监测(CGM)巨头Dexcom领投的7500万美元融资,并建立战略合作伙伴关系,现 ...
University of Galway spinout Luminate raises a further $2.5m, and adds Dexcom executive Steve Pacelli as chair of their Board ...
Dexcom Inc. (NASDAQ:DXCM) 近期报告了一项涉及其执行副总裁兼首席人力资源官Sadie Stern的股票交易。根据SEC Form 4文件显示,Stern于2024年11月20日以每股74.73美元的价格出售了4,259股普通股。此次出售的总价值为318,275美元。
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nurix Therapeutics (NRIX – Research Report), ...
Oura has become incredibly popular in the last few years. The company, originally from Finland, launched its first wearable ...
近日,知名投资机构Dexcom Ventures宣布于2024年11月20日对芬兰智能穿戴监测健康设备研发商Oura Health进行战略投资。 Oura ...